LATEST MANUSCRIPTS IN Clinical and Translational Radiation Oncology
Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Marcel Büttner, Johannes Mücke, Stephan Schönecker, Kristian Unger, Elgin Hoffmann, Frank Paulsen, Daniela Thorwarth, Adrien Holzgreve, Nathalie L Albert, Stefanie Corradini, Ghazaleh Tabatabai, Claus Belka, Maximilian Niyazi. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).Clinical and translational radiation oncology. 2024, 45: 100706
Maiwand Ahmadsei, Vinojaa Jegarajah, Riccardo Dal Bello, Sebastian M Christ, Michael M Mayinger, Luisa Sabrina Stark, Jonas Willmann, Ivan R Vogelius, Panagiotis Balermpas, Nicolaus Andratschke, Stephanie Tanadini-Lang, Matthias Guckenberger. Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors.Clinical and translational radiation oncology. 2024, 45: 100707
Lucas Schoenauen, François-Xavier Stubbe, Dirk Van Gestel, Sébastien Penninckx, Anne-Catherine Heuskin. : A potent model for high-throughput screening experiments investigating the FLASH effect.Clinical and translational radiation oncology. 2024, 45: 100712
Qiuxia Lu, Weisi Yan, Alan Zhu, Slavisa Tubin, Waleed F Mourad, Jun Yang. Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio.Clinical and translational radiation oncology. 2024, 44: 100691
Kendall Kiser, Joshua Schiff, Eric Laugeman, Taeho Kim, Olga Green, Casey Hatscher, Hyun Kim, Shahed Badiyan, Matthew Spraker, Pamela Samson, Clifford Robinson, Alex Price, Lauren Henke. A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry.Clinical and translational radiation oncology. 2024, 44: 100692
Michael Waters, Alex Price, Eric Laugeman, Lauren Henke, Geoff Hugo, Hayley Stowe, Neal Andruska, Randall Brenneman, Yao Hao, Olga Green, Clifford Robinson, Hiram Gay, Jeff Michalski, Brian C Baumann. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.Clinical and translational radiation oncology. 2024, 44: 100693
Víctor Zamora, Olatz Garin, José Francisco Suárez, Cristina Gutiérrez, Ferran Guedea, Patricia Cabrera, Manuel Castells, Ismael Herruzo, Lluis Fumadó, Pilar Samper, Carlos Ferrer, Lucas Regis, Àngels Pont, Montse Ferrer, . Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures.Clinical and translational radiation oncology. 2024, 44: 100694
S van den Bosch, R P Takes, M de Ridder, R de Bree, A Al-Mamgani, W H Schreuder, F J P Hoebers, S van Weert, J B W Elbers, J A Hardillo, T W H Meijer, B E C Plaat, M A de Jong, J C Jansen, D J Wellenstein, G B van den Broek, W V Vogel, A I J Arens, J H A M Kaanders. Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO study.Clinical and translational radiation oncology. 2024, 44: 100696
Sebastian M Christ, Gilbert Youssef, Shyam K Tanguturi, Daniel Cagney, Diana Shi, J Ricardo McFaline-Figueroa, Ugonma Chukwueke, Eudocia Q Lee, Caroline Hertler, Nicolaus Andratschke, Michael Weller, David A Reardon, Daphne Haas-Kogan, Matthias Guckenberger, Patrick Y Wen, Rifaquat Rahman. Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.Clinical and translational radiation oncology. 2024, 44: 100697
Arash Navran, Abrahim Al-Mamgani, Hester Elzinga, Rob Kessels, Conchita Vens, Margot Tesselaar, Michiel van den Brekel, Rosemarie de Haan, Baukelien van Triest, Marcel Verheij. Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma.Clinical and translational radiation oncology. 2024, 44: 100698
Cas Stefaan Dejonckheere, Julian Philipp Layer, Younèss Nour, Katharina Layer, Andrea Glasmacher, Shari Wiegreffe, Arne Fuhrmann, Lara Caglayan, Franziska Grau, Gustavo Renato Sarria, Davide Scafa, David Koch, Martina Heimann, Christina Leitzen, Mümtaz Ali Köksal, Fred Röhner, Thomas Müdder, Egon Dejonckheere, Frederic Carsten Schmeel, Teresa Anzböck, Kira Lindner, Anne Bachmann, Alina Abramian, Christina Kaiser, Andree Faridi, Alexander Mustea, Frank Anton Giordano, Matthias Bernhard Stope, Leo. Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial.Clinical and translational radiation oncology. 2024, 44: 100699
Abdallah S R Mohamed, Geoffrey V Martin, Sweet Ping Ng, Vinita Takiar, Beth M Beadle, Mark Zafereo, Adam S Garden, Steven J Frank, C David Fuller, G Brandon Gunn, William H Morrison, David I Rosenthal, Jay Reddy, Amy Moreno, Anna Lee, Jack Phan. Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation.Clinical and translational radiation oncology. 2024, 44: 100700